The Accuflex decreased the hands-on time by 60% and the analysis time by about 3%. The Hamilton decreased the hands-on time by 80% and the analysis time by 40%. Significant correlation was seen between plasma concentrationsof CRP and IL-6 when the latterwas measured by bioassay; however, IL-6 showed, at best, only a 50% predictive value for a change in CRP concentration. 
mation. The cytokines interleukin (IL)-lp, IL-6, and tumor necrosis factor (TNF) are widely reported to induce synthesis orCRP by hepatocytes both in vitro and in vivo. We investigated the relation between CRP and its cytokine mediatorsin 64 criticallyill patientsduringtheir treatmentin the intensive-care unit. Plasma CRP and IL-6 concentrations were significantly lower in patients without any evidence of infection than in those with clinical infection; plasma IL-i f3 concentrations showed rio significant difference between any of the groups, but plasma TNF concentrations were lower in patients with evidence of infection.
Significant correlation was seen between plasma concentrationsof CRP and IL-6 when the latterwas measured by bioassay; however, IL-6 showed, at best, only a 50% predictive value for a change in CRP concentration. 7) . TNF shares many functions with IL-i, including its ability to induce the production of IL-6 and to directly stimulate hepatocytes to produce acute-phase proteins.
We investigated the relationship between plasma CRP and plasma IL-6, IL-i, and TNF concentrations by simultaneous measurements in 64 patients in the intensive-care unit (ICU). In addition we examined the cytokine and CRP concentrations in these patients during episodes of clinical infection and microbiologically proven infection.
MaterIals and Methods

Specimen collection.
Serial blood samples were collected each morning from 64 patients in the ICU. Whenever the patient had clinical evidence of septicemia, blood cultures, in addition to a specimen for cytokine analysis, were taken. Septicemia was diagnosed by a change in temperature; tachycardia, with or without hypotension; tachypnea or the need for intermittent positive-pressure ventilation; or any two of the general signs of toxicity: metabolic acidosis, arterial hypoxemia, oliguria, coagulopathy and a decrease in platelet count, and deranged hemodynamic data indicating sepsis, i.e., increasing cardiac index and decreasing peripheral vascular resistance.
All blood was collected into sterile pyrogen-free plastic tubes (Flow Laboratories, High Wycombe, UK) containing 50 L of sodium heparin for injection (C P Pharmaceuticals, Wrexham, UK). The specimens were centrifuged for 10 mm at 1000 x g, and the plasma was removed and either analyzed immediately or stored at -30 #{176}C until analysis. A total of 358 specimens were collected.
Plasma measurements.
CRP in plasma was measured by rate nephelometry with an Array analyzer (Beckman, High Wycombe, UK) and had a between-batch coefficient of variation (CV) at both normal and abovenormal concentrations of <7% and a measuring range of 1-600 mgfL. IL-6 in plasma was measured by radioimmunoassay (RIA) (8) and had a between-batch CV of <7% at both low and high concentrations. IL-6 was also The Netherlands) and standardized with mixed lymphocyte-conditioned medium cross-calibrated in the RIA. IL-if3 in plasma was measured by RIA (9) and had a between-batch CV <7% at both low and high concentrations. Plasma TNF was measured by enzyme-linked immunosorbent assay (10) and had a between-batch CV of <10% at both low and high concentrations. All samples received in the laboratory were classified into three groups: those taken at the time of microbiologically proven septicemia were designated MS (n=13), samples taken at the time of clinical septicemia but without microbiological confirmation were designated CS (n=39), and samples taken when there was no clinical evidence of septicemia were designated NS (n=306).
Results
Median plasma concentrations in addition to the minimum and maximum values for CR1', IL-6, IL-i$, and TNF for all 358 samples are shown in Table 1 . Median plasma concentrations and ranges of concentrations for all four analytes for the three sample groups are presented in Table 2 . Plasma CR1' and IL-6 concentrations were significantly lower in the NS group than in the combined MS and CS group. Plasma IL-lp concentrations were not significantly different between any of the groups. Plasma TNF concentration was significantly higher in the NS group than in the combined MS and CS group. Between the two septicemic groups only IL-6 was statistically different, being significantly higher in CS than in MS.
There was no significant correlation between CR1' and IL-1/3, TNF, or IL-6 assayed by RIA (r = 0.022 and Overall, 40 patients stayed in the ICU for 2 days, and there were 265 occasions when results were available for the preceding day. These were classified into three groups: specimens showing a >20% increase in CR1', specimens showing a >20% decrease in CR1', and specimens showing a <20% change in CRP. In each of the three groups, the change in each cytokine concentration was calculated; changes >20% were considered significant.
There was no consistent pattern of change in the three cytokines that was related to a particular change in CR1' concentration (data not presented).
Of the 196 specimens in which IL-6 was measured by bioassay, 169 samples formed part of daily series from individual patients. These specimens were classified into three groups according to the change in CRP, as described above, and analyzed with respect to corre- spending changes in IL-6 concentrations measured by bioassay. An increase in IL-6 concentration followed by an increase in CR1' concentration was considered a true-positive result, as were a decrease in IL-6 concentration followed by a corresponding decrease in CR1' and no IL-6 change followed by no CR1' change. False positives, true negatives, and false negatives were similarly calculated (Table 3) .
Discussion
Diagnosis of septicemia remains a significant problem in critically ill patients, with blood-culture isolation of causative organisms showing low sensitivity as an indicator. We previously reported that daily monitoring of changes in plasma CRP concentrations in IOU patients provides a useful additional marker of sepsis (2).
The measurement in plasma of cytokine inducers of acute-phase protein synthesis may increase both the specificity and sensitivity with which we can detect an acute-phase reaction. Detection of the acute-phase response has historically been in plasma, and detection and quantification of cytokines in plasma may not reflect either effective synthesis or biologically active
protein. In addition, many assays are poorly characterized, being based on antisera raised against recombinant human cytokines and standardized with the same material. Although cytokine assays perform adequately with recombinant material or supernates produced in assay systems in vitro, they are generally poorly characterized for biological material, which may contain a number of undefined interfering substances. Clinical use is also hampered by lack of data concerning the plasma half-life, reference ranges, and magnitude of significant changes during infection and inflammation. It is now well established that IL-6 can stimulate hepatoma cell lines to produce acute-phase proteins; although they are less potent stimulators, both and TNF also induce acute-phase proteins in various hepatoma cultures. In primary hepatocyte cultures, IL-6 is the only one of these three cytokines that induced the full spectrum of acute-phase proteins. That IL-6 and CRP concentrations were significantly higher in the combined MS and CS group than in the NS group is consistent with IL-6 induction of CR1'. However, the lack of correlation between these two markers may reflect insensitivity of the assay or the dynamics of cytokine production in relation to induction of acutephase proteins and to sampling time. Indeed, sensitivity of assay may be a contributing factor, because use of the sensitive bioassay improved correlation, particularly of CRP with IL-6 concentrations of the previous day. The time taken to do a bioassay precludes its use as a predictor of CR1' response, and even if a rapid immunoassay with sensitivity comparable with that of the bioassay were available, at best the predictive value would be only 50% and therefore of no clinical value.
Although IL-i/3 was not significantly different in any of the groups, individual patients showed grossly increased concentrations throughout their investigation, with changes in concentration having no bearing on CRP concentration. This cytokine may not be biologically active in plasma, and indeed binding factors for it do occur (11) . In addition, the plasma concentrations may not truly reflect production, because there is evidence that IL-i is not a conventionally secreted cytokine; rather, it is synthesized as an inactive precursor in the cytosol of activated monocytes and then released via lysosomal vesicles (12).
TNF has been heavily implicated as the mediator of the clinical manifestations of septic shock; however, the literature is conflicting, with reports of both measurable 
